Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now full pipeline small index

Fear: full-pipeline trial registry

4 of 9 indexed Fear trials are currently recruiting.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 4 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Fear: 9 US clinical trials tracked, 4 recruiting.

Fear is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of California, Los Angeles, running 2 of these trials.

Enrollment posture brief

Registry condition fear

OPEN 4 | RECR 44% | LATE 1 | EARLY 1 | RANK #1916 | SPON 2

Nearest open-share peer: Acute Ischemic Stroke (44% recruiting · 27 trials)

Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Fear (this)44%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Fear

Fear lists 4 open slots (44% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Fear on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Fear is recruiting below its size-band peers.

    4 of 9 indexed trials (44.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Fear research.

    University of California, Los Angeles accounts for 2 of 9 trials (22.2%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Typical Fear enrolment sits around 100 participants.

    Median target enrolment is 100 among the 9 trials that report a genuine target (sentinel values excluded). 3 of those (33.3%) plan for fewer than 100 participants.

  4. Fear research is mostly interventional.

    9 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 41

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 4 1

Named interventions

Most-linked intervention names on Fear records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Stigma awareness video intervention Behavioral
1 trials
Informational sheet Behavioral
1 trials
Digital social activity video intervention Behavioral
1 trials
Placebo Pills Drug
1 trials
Estradiol 4Mg Tablet Drug
1 trials
Estradiol 2Mg Tablet Drug
1 trials
Sham intervention control condition Behavioral
1 trials
Attention Training Technique Behavioral
1 trials

US sites by state

Facility locations filed on Fear trials. A trial with sites in several states counts in each.

California 3 trials
New York 2 trials
Pennsylvania 1 trials
Oklahoma 1 trials
North Carolina 1 trials
Massachusetts 1 trials
Illinois 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Fear page

9 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Fear condition card totals 9 registered trials; most-linked intervention Stigma awareness video intervention; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.